Prev
Kansas Attorney General Steve Six filed suit Friday against 13 drug manufacturers, claiming the companies artificially inflated drug prices for medicines commonly prescribed to Medicaid recipients.
MONTGOMERY, Ala. (AP) - A state court jury on Tuesday found two major pharmaceutical companies defrauded Alabama in a long-running Medicaid drug pricing scheme and ordered the firms to pay more than $114 million in damages. The jury found that GlaxoSmithKline should pay the state $80.8 million in compensatory damages and that Novartis should pay about $33.7 million in similar damages. But it declined to order any punitive damages.
WASHINGTON -- More than 400 real estate industry players have been indicted since March -- including dozens over the last two days -- in a Justice Department crackdown on incidents of mortgage fraud nationwide that stem from the country's housing crisis.
An attorney seeking as much as $400 million in damages from two large pharmaceutical companies told jurors Tuesday the firms defrauded Alabama's Medicaid program with high prices for drugs for more than a decade. The trial, expected to last about two weeks, is the second to be held on more than 70 lawsuits filed by the state accusing pharmaceutical companies of overcharging Medicaid for prescription drugs. The first ended with a jury awarding the state $215 million against AstraZeneca Pharmaceuticals LP.
Investors might find it easier to sue insurance agents and carriers, thanks to new standards from the Certified Financial Planner Board of Standards Inc., attorneys said.
A federal judge ruled the Justice Department can subpoena documents and question Countrywide Financial Corp. executives under oath to determine whether the lender abused borrowers and the bankruptcy-court process.
It is recommended that policyholders contact an attorney for legal advice immediately to determine if they should opt out. If policyholders do not opt out by the June 3 deadline, they will not be able to pursue individual litigation if they feel the class action decision is not an adequate remedy or if they file a claim on the policy in the future.
MONTGOMERY, Ala. (AP) — A state court jury has awarded Alabama $215 million in its Medicaid drug price fraud suit against a British pharmaceutical firm.
AstraZeneca Plc said on Thursday it would appeal a jury ruling that it pay $215 million in damages, in an Alabama lawsuit related to drug pricing under the Medicaid health program for the needy.
Beasley Allen Law Firm, 218 Commerce Street, Montgomery, AL 36104
Use of this website signifies your agreement to the Terms of Use and Privacy Policy.
